New drug aims to outperform standard blood thinner for knee surgery patients
NCT ID NCT07140523
Summary
This study is testing a new investigational drug, SRSD107, to see if it works better and is as safe as the standard blood thinner (enoxaparin) at preventing dangerous blood clots after knee replacement surgery. It will involve about 450 adults aged 60-80 who are scheduled for this elective surgery. Researchers will compare three different doses of the new drug against the standard treatment to find the best dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Nové Město na Moravě
RECRUITINGNové Město na Moravě, Czechia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.